Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06614998
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-24
Brief Title:
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center Prospective Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center Prospective Study
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Our three-step screening system uses commonly used clinical and laboratory parameters to effectively identify patients who may be at high risk of HLH conduct etiology screening early for patients who meet the diagnostic criteria for HLH and guide standardized treatment Therefore this study proposes to establish a highly accurate and convenient hemophagocytic early warning system to improve the early diagnosis of patients with hemophagocytic syndrome and identify suspected HLH patients early Etiology screening is performed on patients who meet the diagnostic criteria for HLH high-risk predisposing factors are identified and precise treatment is guided thereby improving the success rate of patient treatment and improving the quality of life
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None